Skip to main content

A Phase I Trial of Fostamatinib before Chronic Graft-vs.-Host Disease Development after Allogeneic Stem Cell Transplantation

Clinical Trial Grant

Administered By

Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

Rigel Inc

Start Date

August 5, 2015

End Date

August 4, 2018
 

Administered By

Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

Rigel Inc

Start Date

August 5, 2015

End Date

August 4, 2018